World's Best Scientists 2026 revealed!
Emmanuel S. Antonarakis

Emmanuel S. Antonarakis

D-Index & Metrics

Medicine

D-Index
87
Citations
37558
World Ranking
13447
National Ranking
6840

Overview

Emmanuel S. Antonarakis is affiliated with the University of Minnesota in the United States and has a significant research presence in medicine, with a focus on oncology and molecular biology. Their work primarily investigates prostate cancer treatment and research, cancer genomics and diagnostics, as well as cancer immunotherapy and biomarkers. Other prominent research areas include radiopharmaceutical chemistry and applications, PARP inhibition in cancer therapy, and cancer metabolism.

Their recent publications include:

  • Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer, 2020, published in JAMA Oncology
  • NCCN Guidelines Insights: Prostate Cancer, Version 1.2021, 2021, published in Journal of the National Comprehensive Cancer Network
  • TMPRSS2 and COVID-19: Serendipity or Opportunity for Intervention?, 2020, published in Cancer Discovery
  • Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials, 2022, published in Journal of Clinical Oncology
  • CDK12-Altered Prostate Cancer: Clinical Features and Therapeutic Outcomes to Standard Systemic Therapies, Poly (ADP-Ribose) Polymerase Inhibitors, and PD-1 Inhibitors, 2020, published in JCO Precision Oncology

Frequent coauthors who have contributed to their work include:

  • Mark C. Markowski
  • Rana R. McKay
  • Samuel R. Denmeade
  • Channing J. Paller
  • Tamara L. Lotan

Their publications are often featured in a variety of clinical and cancer research journals. Frequent publication venues include:

  • Journal of Clinical Oncology (126 papers)
  • The Prostate (17 papers)
  • Annals of Oncology (17 papers)
  • Clinical Cancer Research (13 papers)
  • Cancer Research (13 papers)

In terms of fields of study, their research contributions span:

  • Medicine (707 publications)
  • Biochemistry, Genetics and Molecular Biology (208 publications)

More specific subfields of their work include:

  • Pulmonary and Respiratory Medicine (331 publications)
  • Oncology (175 publications)
  • Cancer Research (111 publications)
  • Radiology, Nuclear Medicine and Imaging (94 publications)
  • Molecular Biology (71 publications)

Main research topics covered in their publications are:

  • Prostate Cancer Treatment and Research (516 publications)
  • Radiopharmaceutical Chemistry and Applications (174 publications)
  • Cancer Immunotherapy and Biomarkers (140 publications)
  • Cancer Genomics and Diagnostics (124 publications)
  • PARP inhibition in cancer therapy (110 publications)
  • Prostate Cancer Diagnosis and Treatment (92 publications)
  • Cancer, Lipids, and Metabolism (68 publications)

Best Publications

  • Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies

    Chetan Bettegowda;Chetan Bettegowda;Mark Sausen;Rebecca J. Leary;Isaac Kinde

  • AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer.

    Emmanuel S. Antonarakis;Changxue Lu;Hao Wang;Brandon Luber

  • Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3

    Howard I. Scher;Michael J. Morris;Walter M. Stadler;Celestia Higano

  • Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

    James L. Mohler;Emmanuel S. Antonarakis;Andrew J. Armstrong;Anthony V. D'Amico

  • Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial

    Ryan Phillips;William Yue Shi;Matthew Deek;Noura Radwan

  • Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer

    Emmanuel S. Antonarakis;Changxue Lu;Brandon Luber;Hao Wang

  • Ruthenium-based chemotherapeutics: are they ready for prime time?

    Emmanuel S. Antonarakis;Ashkan Emadi

  • Pembrolizumab for treatment-refractory metastatic castration-resistant prostate cancer: Multicohort, open-label phase II KEYNOTE-199 study

    Emmanuel S. Antonarakis;Josep M. Piulats;Marine Gross-Goupil;Jeffrey Goh;Jeffrey Goh

  • Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration-Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and Enzalutamide

    Emmanuel S. Antonarakis;Changxue Lu;Brandon Luber;Hao Wang

  • Initial Evaluation of [18F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer

    Zsolt Szabo;Esther Mena;Steven P. Rowe;Donika Plyku

  • Prostate cancer, version 1.2021: Featured updates to the nccn guidelines

    Edward Schaeffer;Sandy Srinivas;Emmanuel S. Antonarakis;Andrew J. Armstrong

  • Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration-resistant Prostate Cancer in the Era of Precision Oncology.

    Philipp Nuhn;Johann S. De Bono;Karim Fizazi;Stephen J. Freedland;Stephen J. Freedland

  • TMPRSS2 and COVID-19: Serendipity or Opportunity for Intervention?

    Konrad H. Stopsack;Lorelei A. Mucci;Emmanuel S. Antonarakis;Peter S. Nelson

  • Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY Study

    Andrew J. Armstrong;Susan Halabi;Jun Luo;David M. Nanus

  • The natural history of metastatic progression in men with prostate-specific antigen recurrence after radical prostatectomy: long-term follow-up.

    Emmanuel S. Antonarakis;Zhaoyong Feng;Bruce J. Trock;Elizabeth B. Humphreys

  • Cabazitaxel: a novel second-line treatment for metastatic castration-resistant prostate cancer

    Channing J Paller;Emmanuel S Antonarakis

  • Effect of bipolar androgen therapy for asymptomatic men with castration-resistant prostate cancer: Results from a pilot clinical study

    Michael T. Schweizer;Emmanuel S. Antonarakis;Hao Wang;A. Seun Ajiboye

  • PSMA-Based [ 18 F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer

    Steven P. Rowe;Katarzyna J. Macura;Esther Mena;Amanda L. Blackford

  • Management of Biochemically Recurrent Prostate Cancer After Local Therapy: Evolving Standards of Care and New Directions

    Channing J. Paller;Emmanuel S. Antonarakis

  • Repurposing Itraconazole as a Treatment for Advanced Prostate Cancer: A Noncomparative Randomized Phase II Trial in Men With Metastatic Castration-Resistant Prostate Cancer

    Emmanuel S. Antonarakis;Elisabeth I. Heath;David C. Smith;Dana Rathkopf

Frequent Co-Authors

Mario A. Eisenberger
Mario A. Eisenberger Johns Hopkins University
Michael A. Carducci
Michael A. Carducci Johns Hopkins University
Charles G. Drake
Charles G. Drake Columbia University
Phuoc T. Tran
Phuoc T. Tran Johns Hopkins University School of Medicine
Howard I. Scher
Howard I. Scher Memorial Sloan Kettering Cancer Center
Andrew J. Armstrong
Andrew J. Armstrong Duke University
Kenneth J. Pienta
Kenneth J. Pienta Johns Hopkins University School of Medicine
Angelo M. De Marzo
Angelo M. De Marzo Johns Hopkins University School of Medicine
Ulka N. Vaishampayan
Ulka N. Vaishampayan University of Michigan–Ann Arbor
Neal D. Shore
Neal D. Shore Carolina Urologic Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative education pathways can help you accelerate your entry into the healthcare field or advance your existing career. Many students are opting for flexible online degrees to suit their schedules and professional aspirations.

For nurses aiming for the highest clinical qualifications without breaking the bank, there are cheapest online dnp programs. These programs provide advanced practice skills at a lower cost, making leadership and specialized practice roles more accessible.

If you’re looking to start your nursing career quickly, fast track lpn programs offer a streamlined curriculum so you can gain licensure and enter the workforce sooner.

Psychiatry and mental health are growing specialties. Those interested can pursue online msn pmhnp programs to become Psychiatric-Mental Health Nurse Practitioners, providing in-demand care in diverse settings.

Beyond clinical roles, students may consider the online healthcare administration degree for careers in hospital management, healthcare consulting, or policy analysis.

Whichever path you choose, online degree options make it easier to align your education with your career goals in medicine and healthcare.

Best Scientists Citing Emmanuel S. Antonarakis

Trending Scientists